日本癌症生物学、生物诊断与治疗的前沿进展
State-of-the-Art Cancer Biology, Biodiagnostics and Therapeutics in Japan.
作者信息
Yamaguchi Junichi, di Luccio Eric, Hirotsu Takaaki
机构信息
Hirotsu Bioscience Inc., New Otani Garden Court 22F, 4-1 Kioi-cho, Chiyoda-ku, Tokyo 102-0094, Japan.
出版信息
Biomedicines. 2023 Oct 26;11(11):2905. doi: 10.3390/biomedicines11112905.
Abstract
Early cancer detection is key to improving patient survival and quality of life and reducing cancer treatments' financial burden [...].
摘要
早期癌症检测是提高患者生存率和生活质量以及减轻癌症治疗经济负担的关键[……]。
相似文献
1
State-of-the-Art Cancer Biology, Biodiagnostics and Therapeutics in Japan.
Biomedicines. 2023 Oct 26;11(11):2905. doi: 10.3390/biomedicines11112905.
2
Influence of financial burden on withdrawal or change of cancer treatment in Japan: results of a bereavement survey.
Support Care Cancer. 2022 Jun;30(6):5115-5123. doi: 10.1007/s00520-022-06933-7. Epub 2022 Mar 1.
3
Financial Literacy, Financial Education, and Cancer Screening Behavior: Evidence from Japan.
Int J Environ Res Public Health. 2022 Apr 7;19(8):4457. doi: 10.3390/ijerph19084457.
4
Financial Burden and Employment Support for Patients with Cancer in Japan: A Review.
Jpn Hosp. 2016 Aug(35):53-76.
5
Retraction statement. Paper by Manizate et al., entitled 'Liver functional reserve estimation: state of the art and relevance to local treatments' Oncology 2010;78(Suppl 1):131-134, DOI: 10.1159/000315241.
Oncology. 2014;87(5):320. doi: 10.1159/000366537. Epub 2014 Sep 3.
6
Depressive symptoms, anxiety, and quality of life of Japanese women at initiation of ART treatment.
Sci Rep. 2021 Apr 6;11(1):7538. doi: 10.1038/s41598-021-87057-6.
7
Japan-China Joint Medical Workshop on Drug Discoveries and Therapeutics 2008: The need of Asian pharmaceutical researchers' cooperation.
Drug Discov Ther. 2008 Oct;2(5):262-3.
8
Population-based assessment of cancer survivors' financial burden and quality of life: a prospective cohort study.
J Oncol Pract. 2015 Mar;11(2):145-50. doi: 10.1200/JOP.2014.001542. Epub 2014 Dec 16.
9
Financial Toxicity: Limitations and Challenges When Caring for Older Adult Patients With Cancer.
Clin J Oncol Nurs. 2018 Dec 1;22(6):43-48. doi: 10.1188/18.CJON.S2.43-48.
10
Increased financial burden among patients with chronic myelogenous leukaemia receiving imatinib in Japan: a retrospective survey.
BMC Cancer. 2012 Apr 24;12:152. doi: 10.1186/1471-2407-12-152.
本文引用的文献
1
Hemoglobin β Expression Is Associated with Poor Prognosis in Clear Cell Renal Cell Carcinoma.
Biomedicines. 2023 Apr 30;11(5):1330. doi: 10.3390/biomedicines11051330.
2
Initial Myeloid Cell Status Is Associated with Clinical Outcomes of Renal Cell Carcinoma.
Biomedicines. 2023 Apr 27;11(5):1296. doi: 10.3390/biomedicines11051296.
3
Mint3 as a Potential Target for Cooling Down HIF-1α-Mediated Inflammation and Cancer Aggressiveness.
Biomedicines. 2023 Feb 14;11(2):549. doi: 10.3390/biomedicines11020549.
4
In Silico Identification of Genes Associated with Breast Cancer Progression and Prognosis and Novel Therapeutic Targets.
Biomedicines. 2022 Nov 21;10(11):2995. doi: 10.3390/biomedicines10112995.
5
The Endometriotic Neoplasm Algorithm for Risk Assessment (e-NARA) Index Sheds Light on the Discrimination of Endometriosis-Associated Ovarian Cancer from Ovarian Endometrioma.
Biomedicines. 2022 Oct 24;10(11):2683. doi: 10.3390/biomedicines10112683.
6
Predictive Risk Factors Associated with Severe Radiation-Induced Mucositis in Nasopharyngeal or Oropharyngeal Cancer Patients: A Retrospective Study.
Biomedicines. 2022 Oct 21;10(10):2661. doi: 10.3390/biomedicines10102661.
7
as a Powerful Tool for Cancer Screening.
Biomedicines. 2022 Sep 23;10(10):2371. doi: 10.3390/biomedicines10102371.
8
RNA Modification in Inflammatory Bowel Diseases.
Biomedicines. 2022 Jul 13;10(7):1695. doi: 10.3390/biomedicines10071695.
9
Brain Cancer Chemotherapy through a Delivery System across the Blood-Brain Barrier into the Brain Based on Receptor-Mediated Transcytosis Using Monoclonal Antibody Conjugates.
Biomedicines. 2022 Jul 5;10(7):1597. doi: 10.3390/biomedicines10071597.
10
EpisomiR, a New Family of miRNAs, and Its Possible Roles in Human Diseases.
Biomedicines. 2022 May 30;10(6):1280. doi: 10.3390/biomedicines10061280.
Zotero 插件